A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects
Clinical trial NCT05384262 · COMPLETED
Trial details
- NCT number
- NCT05384262
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2024-06-14
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.